Gain Therapeutics Inc GANX Q1 2026 Earnings Narrower Loss Surpasses Estimates Stock Edges Higher OPXS Q1 2026 Earnings EPS of 003 Reflects Profitability Revenue Details Not Disclosed ANF Q1 2026 Earnings EPS Beat by 20 as Cost Discipline Drives Profitability FEDU Q4 2019 Earnings Significant EPS Miss Weighs on Shares STXS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Strategic Progress VSEC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat